There is no approved treatment, but there could soon be hope. Based on some promising initial findings, and a new three-year, $21 million grant from the National Institute on Aging, researchers at the University of Miami Miller School of Medicine are launching a Phase 2b study of neflamapimod for Lewy Body dementia.

Click the image below for full article.